Mark Guerin
Financieel Directeur/CFO bij TRAWS PHARMA, INC.
Vermogen: 48 083 $ op 30-04-2024
Actieve functies van Mark Guerin
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
| TRAWS PHARMA, INC. | Financieel Directeur/CFO | 12-02-2016 | - |
| Comptroller/Controller/Auditor | 09-05-2014 | 12-02-2016 | |
| Operationeel Directeur | 10-06-2022 | 01-04-2024 |
Loopbaan van Mark Guerin
Eerdere bekende functies van Mark Guerin
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
CardioKine, Inc.
 CardioKine, Inc. Pharmaceuticals: MajorHealth Technology CardioKine, Inc. develops drugs and pharmaceuticals for the treatment and prevention of heart failure. The company was founded by Arthur Michael Feldman, James Mervis, Paul-Andre de Lame and Michael Juliano in 2004 and is headquartered in Pittsburgh, PA. | Financieel Directeur/CFO | 01-01-2009 | 01-12-2011 |
Barrier Therapeutics, Inc.
 Barrier Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Barrier Therapeutics, Inc. discovers, develops, and commercializes pharmaceutical products in the field of dermatology in the United States. It markets Xolegel, Vusion, and Solage gels. The firm markets its products to dermatologists and other target physicians through sales force. The company was founded in 2001 and is headquartered in Princeton, NJ | Corporate Officer/Principal | - | - |
Opleiding van Mark Guerin
| DeSales University | Undergraduate Degree |
Statistieken
Internationaal
| Verenigde Staten | 5 |
Operationeel
| Director of Finance/CFO | 2 |
| Comptroller/Controller/Auditor | 1 |
| Chief Operating Officer | 1 |
Sectoraal
| Health Technology | 4 |
| Consumer Services | 2 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| TRAWS PHARMA, INC. | Health Technology |
| Bedrijven in privébezit | 2 |
|---|---|
CardioKine, Inc.
CardioKine, Inc. Pharmaceuticals: MajorHealth Technology CardioKine, Inc. develops drugs and pharmaceuticals for the treatment and prevention of heart failure. The company was founded by Arthur Michael Feldman, James Mervis, Paul-Andre de Lame and Michael Juliano in 2004 and is headquartered in Pittsburgh, PA. | Health Technology |
Barrier Therapeutics, Inc.
Barrier Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Barrier Therapeutics, Inc. discovers, develops, and commercializes pharmaceutical products in the field of dermatology in the United States. It markets Xolegel, Vusion, and Solage gels. The firm markets its products to dermatologists and other target physicians through sales force. The company was founded in 2001 and is headquartered in Princeton, NJ | Health Technology |
- Beurs
- Insiders
- Mark Guerin
- Ervaring
